Tetra Discovery Partners, Inc.
HVAC system installation marketplace connecting homeowners with local installers
- Sector
- Medtech
- Headquarters
- GRAND RAPIDS, MI
- Founded
- 2016
- Latest Form D
- $35.8M, Jan 2019
- Total capital
- $53.2M
- Federal grants
- $12.7M
- 12 awards · 2015–2020
- Rank in peer group#2 of 41
- Private capital raised
- $40.5M
- 3 Form D · last Jan 2019
- 94 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 5 pending · first 2021
- Rank in peer group#9 of 41
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · PDE4D PET Ligand$625K
- Private capital raisedForm D · SEC · 3rd filing$35.8M
- Federal grantHealth and Human S · Phase II · Phosphodiesterase-4B (PDE4B) Inhibitors for Alzheimer's Disease$412K
- Federal grantHealth and Human S · Phase II · Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease$982K
- Federal grantHealth and Human S · Phase II · PDE4D PET Ligand$1.6M
- Federal grantHealth and Human S · Phase II · BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects$109K
- Federal grantHealth and Human S · Phase II · Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease$987K
- Private capital raisedForm D · SEC · 2nd filing$505K
- Private capital raisedForm D · SEC · 1st filing$4.3M
Show 6 earlier federal awards
- Federal grantHealth and Human S · Phase II · Phosphodiesterase-4B (PDE4B) Inhibitors for Alzheimer's Disease$3.4M
- Federal grantHealth and Human S · Phase II · Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease$991K
- Federal grantHealth and Human S · Phase II · BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects$2.1M
- Federal grantHealth and Human S · Phase II · PDE4B Inhibitors For Treating Major Depression$1M
- Federal grantHealth and Human S · Phase I · PDE4D PET Ligand for Psychiatric Disease$346K
- Federal grantHealth and Human S · Phase I · PDE4B Inhibitors for Treating Brain Injury$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
15months
from Tetra Discovery Partners, Inc.’s first federal award to its first private round.
- First federal award · May 2015
- Health and Human S · $225K
- First Form D · Aug 2016
- $4.3M · 1st Form D
- Awards before first raise
- 3 awards
An association in public records, not a cause or a prediction.
Standing among 41 peers
Line = medianMedtech · Molecule
- Federal grants#2 · top 5%
- Granted patents#9 · top 22%
- Linked publications#3 · top 7%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Mark GurneyResearcherExecutive Officer, DirectorLinked by 2 patents · $12.7M in grants as PI
- Donald ParfetDirectorNamed in SEC Form D filings
- Douglas MortonDirectorNamed in SEC Form D filings
- Joseph CollardDirectorNamed in SEC Form D filings
- Lance StewartDirectorNamed in SEC Form D filings
- Paul D'AmatoDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 7- GrantedPDE4D InhibitorsUSPTOUS 11,104,660
- GrantedSalts And Polymorphs Of A PDE4 InhibitorUSPTOUS 11,028,050
- PendingPDE4D InhibitorsUSPTOApplication PCTUS2020029427
Show all 7 patent records
- PDE4D InhibitorsAug 31, 2021 · US 11,104,660Granted
- Salts And Polymorphs Of A PDE4 InhibitorJun 8, 2021 · US 11,028,050Granted
- PDE4D InhibitorsApplication PCTUS2020029427Pending
- Aromatic Heterocycle Derivatives And Aromatic Carbocycle Derivatives Having PDE4D Inhibitory ActivityApplication 63648888Pending
- Salts And Polymorphs Of A PDE4 InhibitorApplication PCTUS2020028616Pending
- PDE4D InhibitorsApplication 62837297Pending
- Salts And Polymorphs Of A PDE4 InhibitorApplication 62835867Pending
Recent research by its founders
- Sexual Differentiation of Brain and Behavior in the Zebra Finch (Poephila guttata): a Cellular Analysis20260 cites
- Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study202523 cites
- ROC Analysis of Biomarker Combinations in Fragile X Syndrome-Specific Clinical Trials: Evaluating Treatment Efficacy via Exploratory Biomarkers20251 cites
Related companies, and why
- Octave Bioscience IncSimilar federal contract value in Medtech · null in contracts
- Scilex Holding CoSimilar federal contract value in Medtech · null in contracts
- Binx HealthSimilar federal contract value in Medtech · null in contracts
- DesertDx, LLCSimilar federal contract value in Medtech · null in contracts
- SunBird BioSimilar federal contract value in Medtech · null in contracts
- GI DYNAMICS, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .